Clinical Trial: Efficacy and Tolerability of BAF312 in Patients With Polymyositis

Study Status: Terminated
Recruit Status: Terminated
Study Type: Interventional




Official Title: A Multi-centre Double-blind, Placebo Controlled, Proof of Concept Study to Evaluate the Efficacy and Tolerability of BAF312 in Patients With Polymyositis

Brief Summary: This study will assess the efficacy, safety and tolerability of BAF312 administered orally in patients with clinically active polymyositis and also in patients with polymyositis who have shown inadequate response to corticosteroids and or DMARDs (disease modifying antirheumatic drugs).